The four stories are part of my health beat reporting in 2013. The first was a deep dive into the decision by a small physician’s clinic to ban pharmaceutical drug reps. It was followed by a story about a pharmaceutical company that gained additional years of brand name protection by putting a capsule around the same pill they’d been selling for years. The third story chronicles the story of an infant with baby botulism, saved by a physician’s recollection of a case 20 years earlier, and the great lengths taken by a health department to make the antitoxin available. The final story examines the validity of a commonly used concussion baseline testing program.
